Articles liés à The Efficacy Of Ranibizumab In The Treatment Of Macular...
Synopsis
Retinal vein occlusion ( RVO ) causes significant visual loss in patients with medical diseases especially systemic hypertension . Centrally involving macular edema is the main cause of loss of vision in such patients . previous treatment strategies for macular edema involve argon laser retinal photocoagulation , Radial optic neurotomy, intravitreal injections of steroids but recently the introduction of anti-vascular endothelial growth factor medications represents a breakthrough and has revolutionized the treatment of retinal vein occlusion associated macular edema in addition to the beneficial effect of suppressing the risky retinal neovascularization . Ranibizumab ( Lucentis ) is one of the most commonly used Anti-VEGF drugs in treatment of macular edema associated with retinal vein occlusion RVO whether the central type ( CRVO ) or the branch type ( BRVO ) .
Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.
Résultats de recherche pour The Efficacy Of Ranibizumab In The Treatment Of Macular...
Image fournie par le vendeur
The Efficacy Of Ranibizumab In The Treatment Of Macular Edema Second
Edité par
Noor Publishing Jun 2017, 2017
ISBN 10 : 3330854952
ISBN 13 : 9783330854956
Neuf
Taschenbuch
Vendeur : BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Allemagne
Évaluation du vendeur 5 sur 5 étoiles
Taschenbuch. Etat : Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Retinal vein occlusion ( RVO ) causes significant visual loss in patients with medical diseases especially systemic hypertension . Centrally involving macular edema is the main cause of loss of vision in such patients . previous treatment strategies for macular edema involve argon laser retinal photocoagulation , Radial optic neurotomy, intravitreal injections of steroids but recently the introduction of anti-vascular endothelial growth factor medications represents a breakthrough and has revolutionized the treatment of retinal vein occlusion associated macular edema in addition to the beneficial effect of suppressing the risky retinal neovascularization . Ranibizumab ( Lucentis ) is one of the most commonly used Anti-VEGF drugs in treatment of macular edema associated with retinal vein occlusion RVO whether the central type ( CRVO ) or the branch type ( BRVO ) . 100 pp. Englisch. N° de réf. du vendeur 9783330854956
Acheter neuf
EUR 49,90
Expédition à EUR 23
Expédition depuis Allemagne vers Etats-Unis
Expédition depuis Allemagne vers Etats-Unis
Quantité disponible : 2 disponible(s)
Image fournie par le vendeur
The Efficacy Of Ranibizumab In The Treatment Of Macular Edema Second
impression à la demandeVendeur : AHA-BUCH GmbH, Einbeck, Allemagne
Évaluation du vendeur 5 sur 5 étoiles
Taschenbuch. Etat : Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Retinal vein occlusion ( RVO ) causes significant visual loss in patients with medical diseases especially systemic hypertension . Centrally involving macular edema is the main cause of loss of vision in such patients . previous treatment strategies for macular edema involve argon laser retinal photocoagulation , Radial optic neurotomy, intravitreal injections of steroids but recently the introduction of anti-vascular endothelial growth factor medications represents a breakthrough and has revolutionized the treatment of retinal vein occlusion associated macular edema in addition to the beneficial effect of suppressing the risky retinal neovascularization . Ranibizumab ( Lucentis ) is one of the most commonly used Anti-VEGF drugs in treatment of macular edema associated with retinal vein occlusion RVO whether the central type ( CRVO ) or the branch type ( BRVO ) . N° de réf. du vendeur 9783330854956
Acheter neuf
EUR 55,58
Expédition à EUR 35
Expédition depuis Allemagne vers Etats-Unis
Expédition depuis Allemagne vers Etats-Unis
Quantité disponible : 1 disponible(s)
Image fournie par le vendeur
The Efficacy Of Ranibizumab In The Treatment Of Macular Edema Second
impression à la demandeVendeur : moluna, Greven, Allemagne
Évaluation du vendeur 5 sur 5 étoiles
Etat : New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: Abdel-Radi Abdel-Salam MahmoudThe research book was to evaluate the efficacy of ranibizumab (Lucentis) injection in treating patients with CRVO & BRVO induced macular edemaand to compare its efficacy in ischemic versus perfused for. N° de réf. du vendeur 153339871
Acheter neuf
EUR 41,71
Expédition à EUR 48,99
Expédition depuis Allemagne vers Etats-Unis
Expédition depuis Allemagne vers Etats-Unis
Quantité disponible : Plus de 20 disponibles
Image d'archives
The Efficacy Of Ranibizumab In The Treatment Of Macular Edema Second
Vendeur : Revaluation Books, Exeter, Royaume-Uni
Évaluation du vendeur 5 sur 5 étoiles
Paperback. Etat : Brand New. 100 pages. 8.66x5.91x0.23 inches. In Stock. N° de réf. du vendeur 3330854952
Acheter neuf
EUR 90,47
Expédition à EUR 11,94
Expédition depuis Royaume-Uni vers Etats-Unis
Expédition depuis Royaume-Uni vers Etats-Unis
Quantité disponible : 1 disponible(s)
Image fournie par le vendeur
The Efficacy Of Ranibizumab In The Treatment Of Macular Edema Second
Edité par
Noor Publishing Jun 2017, 2017
ISBN 10 : 3330854952
ISBN 13 : 9783330854956
Neuf
Taschenbuch
Vendeur : buchversandmimpf2000, Emtmannsberg, BAYE, Allemagne
Évaluation du vendeur 5 sur 5 étoiles
Taschenbuch. Etat : Neu. This item is printed on demand - Print on Demand Titel. Neuware -Retinal vein occlusion ( RVO ) causes significant visual loss in patients with medical diseases especially systemic hypertension . Centrally involving macular edema is the main cause of loss of vision in such patients . previous treatment strategies for macular edema involve argon laser retinal photocoagulation , Radial optic neurotomy, intravitreal injections of steroids but recently the introduction of anti-vascular endothelial growth factor medications represents a breakthrough and has revolutionized the treatment of retinal vein occlusion associated macular edema in addition to the beneficial effect of suppressing the risky retinal neovascularization . Ranibizumab ( Lucentis ) is one of the most commonly used Anti-VEGF drugs in treatment of macular edema associated with retinal vein occlusion RVO whether the central type ( CRVO ) or the branch type ( BRVO ) .Books on Demand GmbH, Überseering 33, 22297 Hamburg 100 pp. Englisch. N° de réf. du vendeur 9783330854956
Acheter neuf
EUR 49,90
Expédition à EUR 60
Expédition depuis Allemagne vers Etats-Unis
Expédition depuis Allemagne vers Etats-Unis
Quantité disponible : 1 disponible(s)